|
|
Article: Inflammatory Diseases - Both Chronic Diseases, Such as Rheumatoid Arthritis (RA), and Acute Diseases, Such as Septic Shock-Pose a Substantial Economic Burden.
- Article from:
- Business Wire
- Article date:
- February 1, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c32007) has announced the addition of Cytokine Therapeutics: Current and Future Markets in Inflammatory Disease to their offering.
According to this Decision Resources report, inflammatory diseases affect more than 500 million patients in the major pharmaceutical markets, and total prevalence is growing. In the treatment of these diseases, cytokine therapeutic agents play a major role. The five cytokine agents that have reached the U.S. and European markets so far have achieved major commercial success: in 2004, the value of the global anti-inflammatory cytokines market was $6.5 ...